FDA warns of risks with Trump-promoted malaria drug

The US Food and Drug Administration is warning doctors against prescribing a malaria drug widely touted by US President Donald Trump for treating the new coronavirus outside of hospitals or research settings.

In an alert Friday, regulators warned of reports of serious side effects and death among patients taking hydroxychloroquine and the related drug chloroquine. The drugs, also approved for lupus, can cause a number of side effects, including dangerous irregular heart rhythms.

— AP

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.